Human Papillomavirus Infection and Esophageal Squamous Cell Carcinoma: A Case–Control Study

Fangcen Guo,Ying Liu,Xueqian Wang,Zhonghu He,Noel S. Weiss,Margaret M. Madeleine,Fangfang Liu,Xiuyun Tian,Yuqin Song,Yaqi Pan,Tao Ning,Haijun Yang,Xiaotian Shi,Changdong Lu,Hong Cai,Yang Ke
DOI: https://doi.org/10.1158/1055-9965.epi-11-1206
2012-01-01
Cancer Epidemiology Biomarkers & Prevention
Abstract:Background: The risk factors for esophageal squamous cell carcinoma (ESCC) in the high-incidence areas of China remain unclear. Methods: A total of 300 patients with ESCC and 900 controls matched for age and sex were enrolled in Anyang (China), a high-risk area for ESCC in China. In tumor tissue of the cases and in esophageal biopsies of controls, the presence of human papillomavirus (HPV) DNA was assessed by an SPF1/GP6+-mediated PCR followed by sequencing. The presence of serum antibody against the HPV-16 E7 oncoprotein was assessed by use of the ELISA. ORs with 95% confidence intervals (CI) were calculated via unconditional logistic regression models. Results: The presence of HPV in the esophagus (OR, 6.4; 95% CI, 4.4–9.2) was associated with increased risk of ESCC. Moreover, infection with “oncogenic” types of HPV (OR, 10.3; 95% CI, 6.3–16.8) was more strongly associated with ESCC than other types of HPV (OR, 2.4; 95% CI, 1.4–4.2). The presence of HPV-16 (OR, 12.8; 95% CI, 7.6–21.7) was particularly strongly associated with ESCC. In addition, a higher proportion of cases than controls had serum antibodies against HPV-16 E7 (OR, 6.1; 95% CI, 3.7–10.0). Conclusion and Impact: This study provides the strongest epidemiologic evidence to date in support of the important role of HPV in the development of ESCC in high-incidence areas of China. Cancer Epidemiol Biomarkers Prev; 21(5); 780–5. ©2012 AACR.
What problem does this paper attempt to address?